These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 225066)

  • 1. Plasma renin activity and aldosterone concentration in normal subjects and patients with salt-losing type of congenital adrenal hyperplasia during infancy.
    Koshimizu T
    Clin Endocrinol (Oxf); 1979 May; 10(5):515-22. PubMed ID: 225066
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma aldosterone, renin activity, and 17alpha-hydroxyprogesterone in salt-losing congenital adrenal hyperplasia. I. Response to ACTH in hydrocortisone treated patients and effect of 9alpha-fluorocortisol.
    Limal JM; Rappaport R; Bayard F
    J Clin Endocrinol Metab; 1977 Sep; 45(3):551-9. PubMed ID: 198427
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of renin and angiotensin in salt-losing, 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Horner JM; Hintz RL; Luetscher JA
    J Clin Endocrinol Metab; 1979 May; 48(5):776-83. PubMed ID: 219009
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma renin activity in congenital virilizing adrenal hyperplasia.
    Imai M; Igarashi Y; Sokabe H
    Pediatrics; 1968 May; 41(5):897-904. PubMed ID: 5654837
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital adrenal hyperplasia: simultaneous determination of plasma aldosterone and 17-hydroxyprogesterone.
    Parth K; Zimprich H; Swoboda W; Brunel R; Bohrn E
    Acta Endocrinol (Copenh); 1978 Jan; 87(1):148-57. PubMed ID: 202131
    [No Abstract]   [Full Text] [Related]  

  • 6. Renin substrate depletion in salt-losing congenital virilizing adrenal hyperplasia: low plasma renin activity despite increased renin concentration.
    Rosenthal SM; Reid IA; Kaplan SL; Grumbach MM
    J Pediatr; 1983 Jan; 102(1):80-2. PubMed ID: 6294266
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium homeostasis and aldosterone secretion in salt-losing congenital adrenal hyperplasia.
    Keenan BS; Holcombe JH; Kirkland RT; Potts VE; Clayton GW
    J Clin Endocrinol Metab; 1979 Mar; 48(3):430-6. PubMed ID: 429496
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma renin activity and aldosterone secretion in congenital adrenal hyperplasia.
    Godard C; Riondel AM; Veyrat R; Mégevand A; Muller AF
    Pediatrics; 1968 May; 41(5):883-904. PubMed ID: 5654836
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma aldosterone concentrations related to 17alpha-hydroxyprogesterone in congenital adrenal hyperplasia.
    Pham-Huu-Trung MT; Raux MC; Gourmelen M; Baron MC; Girard F
    Acta Endocrinol (Copenh); 1976 Jul; 82(3):572-86. PubMed ID: 180741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone-to-renin ratio as a marker for disease severity in 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Nimkarn S; Lin-Su K; Berglind N; Wilson RC; New MI
    J Clin Endocrinol Metab; 2007 Jan; 92(1):137-42. PubMed ID: 17032723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interrelationship of sodium balance, plasma renin activity and ACTH in congenital adrenal hyperplasia.
    Rösler A; Levine LS; Schneider B; Novogroder M; New MI
    J Clin Endocrinol Metab; 1977 Sep; 45(3):500-12. PubMed ID: 198425
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension.
    Kem DC; Weinberger MH; Higgins JR; Kramer NJ; Gomez-Sanchez C; Holland OB
    J Clin Endocrinol Metab; 1978 Apr; 46(4):552-60. PubMed ID: 225341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renin-angiotensin and hypophyseo-adrenal systems in children suffering from congenital adrenocortical hyperplasia resulting from 21-hydroxylase deficiency].
    Kasatkina EP; Tiul'pakov AN; Ibragimova GV; Litvinova NN
    Probl Endokrinol (Mosk); 1991; 37(6):p66. PubMed ID: 1664952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siblings of 21-hydroxylase deficiency (non-salt-losing) with aldosterone hypersecretion.
    Morimoto I; Yamamoto S; Tateishi H; Ueda S; Toda Y; Zeki K; Watanabe K; Nakano Y; Kashimura M; Eto S
    Intern Med; 1992 May; 31(5):690-4. PubMed ID: 1324037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of the renin-aldosterone system in congenital adrenal hyperplasia.
    Strickland AL; Kotchen TA
    J Pediatr; 1972 Nov; 81(5):962-9. PubMed ID: 5086723
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrenal gland carcinoma with mineralocorticoidism, increased plasma-renin activity and normal plasma aldosterone].
    Rössler R; Klaus D; Klumpp F; Meyer D
    Med Welt; 1973 Oct; 24(43):1644-7. PubMed ID: 4764058
    [No Abstract]   [Full Text] [Related]  

  • 17. Early diagnosis of salt-losing congenital adrenal hyperplasia in a newborn boy.
    Hughes IA; Winter JS
    Can Med Assoc J; 1977 Aug; 117(4):363-5. PubMed ID: 890632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new form of congenital adrenal hyperplasia.
    New MI; Peterson RE
    J Clin Endocrinol Metab; 1967 Feb; 27(2):300-5. PubMed ID: 6018580
    [No Abstract]   [Full Text] [Related]  

  • 19. ALDOSTERONE- AND CORTISOL SECRETION RATES IN INFANTS AND CHILDREN WITH CONGENITAL ADRENAL HYPERPLASIA SUGGESTING DIFFERENT 21-HYDROXYLATION DEFECTS IN "SALT-LOSERS" AND "NON SALT-LOSERS".
    DEGENHART HJ; VISSER HK; WILMINK R; CROUGHS W
    Acta Endocrinol (Copenh); 1965 Apr; 48():587-601. PubMed ID: 14288879
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of ACTH administration on aldosterone production in non salt-losing congenital adrenal hyperplasia.
    Beitins IZ; Bayard F; Kowarski A; Migeon CJ
    J Clin Endocrinol Metab; 1972 Oct; 35(4):595-603. PubMed ID: 4340790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.